- Home
- FIVN vs ATAI Comparison
FIVN vs ATAI Comparison
Compare FIVN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVN | ATAI |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FIVN | ATAI |
|---|---|---|
| Price | $19.39 | $3.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $32.13 | $14.33 |
| AVG Volume (30 Days) | 1.6M | ★ 3.4M |
| Earning Date | 02-19-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $1,127,466,000.00 | $3,018,000.00 |
| Revenue This Year | $12.29 | $943.18 |
| Revenue Next Year | $9.40 | N/A |
| P/E Ratio | $54.43 | ★ N/A |
| Revenue Growth | 12.48 | ★ 811.78 |
| 52 Week Low | $17.71 | $1.15 |
| 52 Week High | $49.90 | $6.75 |
Technical Indicators
Market Signals| Indicator | FIVN | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 39.97 |
| Support Level | $18.41 | $3.64 |
| Resistance Level | $20.11 | $4.14 |
| Average True Range (ATR) | 0.67 | 0.24 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 44.95 | 15.28 |
Price Performance
Historical ComparisonAbout FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.